COVID-19 vaccination is associated with lower mortality and intensive care unit admission among hospitalized patients with COVID-19: A retrospective cohort study
Keywords:
Computed tomography, COVID-19, hospitalized patients, ICU admission, mortality, SARS-CoV-2, vaccinationAbstract
Background: Vaccination has been central to reducing severe coronavirus disease 2019 (COVID-19). However, the association between prior vaccination and outcomes among patients hospitalized with COVID-19 remains clinically relevant.
Objective: To investigate the association between COVID-19 vaccination status and mortality and intensive care unit (ICU) admission among hospitalized patients with COVID-19.
Methods: This retrospective single-center cohort study included adults hospitalized with reverse transcription polymerase chain reaction -confirmed COVID-19 between July 2021 and February 2022 who had documented vaccination status and underwent at least one chest computed tomography (CT) scan. The exposure of interest was full COVID-19 vaccination. Primary outcomes were mortality and intensive care unit (ICU) admission. Associations were examined using regression models adjusted for age, type 2 diabetes, hypertension, cardiac disease, and pulmonary disease. Exploratory predictor analyses were performed using Least Absolute Shrinkage and Selection Operator (LASSO) regression.
Results: The analytic cohort comprised 167 patients: 69.0% were male, mean age was 58 years (95% CI [55 60]), and 42.0% were fully vaccinated. Full vaccination was associated with lower adjusted relative risk of mortality (RR: 0.46, 95% CI [0.13 0.99]) and ICU admission (RR: 0.59, 95% CI [0.28 0.89]). The adjusted absolute risk difference for ICU admission corresponded to an observational number needed to treat like estimate of four, which should be interpreted cautiously. In patients younger than 60 years, vaccination was associated with fewer ICU admissions (RR: 0.64, 95% CI [0.32 0.99]).
Conclusion: COVID-19 vaccination was associated with lower mortality and reduced ICU admission among hospitalized patients with COVID-19 in this retrospective single-center cohort. Because of the observational design, selected hospitalized CT-imaged population, and potential residual confounding, these findings should be interpreted as associations rather than proof of causal protection.
Downloads
References
Karim SSA, Karim QA. Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic. Lancet 2021;398:2126-8.
https://doi.org/10.1016/S0140-6736(21)02758-6
Fontanet A, Autran B, Lina B, Kieny MP, Karim SSA, et al. SARS-CoV-2 variants and ending the COVID-19 pandemic. Lancet 2021;397:952-4.
https://doi.org/10.1016/S0140-6736(21)00370-6
Matthay MA, Zemans RL, Zimmerman GA, Arabi YM, Beitler JR, Mercat A, et al. Acute respiratory distress syndrome. Nat Rev Dis Primers 2019; 5:18.
https://doi.org/10.1038/s41572-019-0069-0
Sarkesh A, Daei Sorkhabi A, Sheykhsaran E, Alinezhad F, Mohammadzadeh N, Hemmat N, et al. Extrapulmonary Clinical manifestations in COVID-19 patients. Am J Trop Med Hyg 2020;103:1783-96
https://doi.org/10.4269/ajtmh.20-0986
Subudhi S, Verma A, Patel AB, Hardin CC, Khandekar MJ, Lee H, et al. Comparing machine learning algorithms for predicting ICU admission and mortality in COVID-19. NPJ Digit Med 2021;4:87.
https://doi.org/10.1038/s41746-021-00456-x
Li CX, Noreen S, Zhang LX, Saeed M, Wu PF, Ijaz M, et al. A critical analysis of SARS-CoV-2 (COVID-19) complexities, emerging variants, and therapeutic interventions and vaccination strategies. Biomed Pharmacother 2022;146:112550.
https://doi.org/10.1016/j.biopha.2021.112550
Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med 2020;383:2603-15.
https://doi.org/10.1056/NEJMoa2034577
Askani E, Mueller-Peltzer K, Madrid J, Knoke M, Hasic D, Schlett CL, et al. Pulmonary computed tomographic manifestations of COVID-19 in vaccinated and non-vaccinated patients. Sci Rep 2023;13:6884.
https://doi.org/10.1038/s41598-023-33942-1
Askani E, Mueller-Peltzer K, Madrid J, Knoke M, Hasic D, Bamberg F, et al. Computed Tomographic Imaging Features of COVID-19 Pneumonia Caused by the Delta (B.1.617.2) and Omicron (B.1.1.529) Variant in a German Nested Cohort Pilot Study Group. Tomography 2022;8:2435-49.
https://doi.org/10.3390/tomography8050202
Madrid J, Agarwal P, Müller-Peltzer K, Askani M, Benning L, Selig M, et al. Vaccination protects against acute respiratory distress syndrome (ARDS) in hospitalized patients with COVID-19. Clin Exp Med 2024;24:21.
https://doi.org/10.1007/s10238-023-01293-w
Madrid J, Agarwal P, Müller-Peltzer K, Benning L, Selig M, Rolauffs B, et al. Cardioprotective effects of vaccination in hospitalized patients with COVID-19. Clin Exp Med 2024;24:103.
https://doi.org/10.1007/s10238-024-01367-3
Nakagawa S, Cuthill IC. Effect size, confidence interval and statistical significance: a practical guide for biologists. Biol Rev Camb Philos Soc 2007;82:591-605.
https://doi.org/10.1111/j.1469-185X.2007.00027.x
Bahl A, Johnson S, Maine G, Garcia MH, Nimmagadda S, Qu L, et al. Vaccination reduces need for emergency care in breakthrough COVID-19 infections: A multicenter cohort study. Lancet Reg Health Am 2021;4:100065.
https://doi.org/10.1016/j.lana.2021.100065
Weatherhead JE, Clark E, Vogel TP, Atmar RL, Kulkarni PA. Inflammatory syndromes associated with SARS-CoV-2 infection: dysregulation of the immune response across the age spectrum. J Clin Invest 2020;130:6194-7.
https://doi.org/10.1172/JCI145301
Tian W, Zhang N, Jin R, Feng Y, Wang S, Gao S, et al. Immune suppression in the early stage of COVID-19 disease. Nat Commun 2020;11:5859
https://doi.org/10.1038/s41467-020-19706-9
McGonagle D, Sharif K, O'Regan A, Bridgewood C. The Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease. Autoimmun Rev 2020;19:102537.
https://doi.org/10.1016/j.autrev.2020.102537
Levine-Tiefenbrun M, Yelin I, Katz R, Herzel E, Golan Z, Schreiber L, et al. Initial report of decreased SARS-CoV-2 viral load after inoculation with the BNT162b2 vaccine. Nat Med 2021;27:790-2.
https://doi.org/10.1038/s41591-021-01316-7
Earle KA, Ambrosino DM, Fiore-Gartland A, Goldblatt D, Gilbert PB, Siber GR, et al. Evidence for antibody as a protective correlate for COVID-19 vaccines. Vaccine 2021;39: 423-8.
https://doi.org/10.1016/j.vaccine.2021.05.063
Singh AK, Gupta R, Ghosh A, Misra A. Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations. Diabetes Metab Syndr 2020;14:303-10.
https://doi.org/10.1016/j.dsx.2020.04.004
Zhou W, Sailani MR, Contrepois K, Zhou Y, Ahadi S, Leopold SR, et al. Longitudinal multi-omics of host-microbe dynamics in prediabetes. Nature 2019;569:663-71.
https://doi.org/10.1038/s41586-019-1236-x
Davidson AM, Wysocki J, Batlle D. Interaction of SARS-CoV-2 and other coronavirus with ACE (Angiotensin-Converting Enzyme)-2 as their main receptor. Hypertension 2020;76:1339-49.
https://doi.org/10.1161/HYPERTENSIONAHA.120.15256
Conway EM, Mackman N, Warren RQ, Wolberg AS, Mosnier LO, Campbell RA, et al. Understanding COVID-19-associated coagulopathy. Nat Rev Immunol 2022;22:639-49.
https://doi.org/10.1038/s41577-022-00762-9
Dupont A, Rauch A, Staessens S, Moussa M, Rosa M, Corseaux D, et al. Vascular endothelial damage in the pathogenesis of organ injury in severe COVID-19. Arterioscler Thromb Vasc Biol 2021;41:1760-73.
https://doi.org/10.1161/ATVBAHA.120.315595
Falcón-Cama V, Montero-González T, Acosta-Medina EF, Guillen-Nieto G, Berlanga-Acosta J, Fernández-Ortega C, et al. Evidence of SARS-CoV-2 infection in postmortem lung, kidney, and liver samples, revealing cellular targets involved in COVID-19 pathogenesis. Arch Virol 2023;168:96.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Chulalongkorn Medical Journal

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.






